• 39 Citations
  • 4 h-Index
20182018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Maria Gabriella Ferrandina is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Uterine Cervical Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Neoadjuvant Therapy Medicine & Life Sciences
Lymph Node Excision Medicine & Life Sciences
Robotics Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
BRCA2 Gene Medicine & Life Sciences
Gestational Trophoblastic Disease Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2018 2018

  • 39 Citations
  • 4 h-Index
  • 14 Article
  • 2 Comment/debate
  • 1 Letter

A turning point in the fight against ovarian cancer?

Scambia, G. & Ferrandina, G., Feb 1 2018, In : The Lancet Oncology. 19, 2, p. 154-156 3 p.

Research output: Contribution to journalComment/debate

5 Citations (Scopus)

A whole germline BRCA2 gene deletion: How to learn from CNV in silico analysis

Scaglione, G. L., Concolino, P., De Bonis, M., De Paolis, E., Minucci, A., Ferrandina, G., Scambia, G. & Capoluongo, E., Apr 1 2018, In : International Journal of Molecular Sciences. 19, 4, 961.

Research output: Contribution to journalArticle

BRCA2 Gene
deletion
sequencing
Multiplex Polymerase Chain Reaction
Gene Deletion

Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study

Mangili, G., Cioffi, R., Danese, S., Frigerio, L., Ferrandina, M. G., Cormio, G., Rabaiotti, E., Scarfone, G., Gadducci, A., Bergamini, A., Pisano, C. & Candiani, M., Dec 2018, In : Gynecologic Oncology. 151, 3, p. 449-452 4 p.

Research output: Contribution to journalArticle

Gestational Trophoblastic Disease
Methotrexate
Therapeutics
Leucovorin
Multicenter Studies
1 Citation (Scopus)
Chemotherapy
Carboplatin
Adjuvant Chemotherapy
Paclitaxel
Uterine Cervical Neoplasms
2 Citations (Scopus)
Brachytherapy
Pathologic Constriction
Radiotherapy
Survival Rate
Survival